documents: FDA-1997-N-0041-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1997-N-0041-0003 | FDA | FDA-1997-N-0041 | Prescription Drug Products; Levothyroxine Sodium; Extension of Compliance Date | Notice | N-Notice | 2000-04-26T04:00:00Z | 2000 | 4 | 2009-01-24T19:56:57Z | 0 | 0 | 09000064805cfc27 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref